These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19088036)

  • 41. SNP-based large-scale identification of allele-specific gene expression in human B cells.
    Song MY; Kim HE; Kim S; Choi IH; Lee JK
    Gene; 2012 Feb; 493(2):211-8. PubMed ID: 22178530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrated analysis of copy number alterations and loss of heterozygosity in human pancreatic cancer using a high-resolution, single nucleotide polymorphism array.
    Lin LJ; Asaoka Y; Tada M; Sanada M; Nannya Y; Tanaka Y; Tateishi K; Ohta M; Seto M; Sasahira N; Tada M; Kawabe T; Zheng CQ; Kanai F; Ogawa S; Omata M
    Oncology; 2008; 75(1-2):102-12. PubMed ID: 18787345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis in 117 patients referred for cytogenetic analysis and impact on clinical practice.
    Bruno DL; Ganesamoorthy D; Schoumans J; Bankier A; Coman D; Delatycki M; Gardner RJ; Hunter M; James PA; Kannu P; McGillivray G; Pachter N; Peters H; Rieubland C; Savarirayan R; Scheffer IE; Sheffield L; Tan T; White SM; Yeung A; Bowman Z; Ngo C; Choy KW; Cacheux V; Wong L; Amor DJ; Slater HR
    J Med Genet; 2009 Feb; 46(2):123-31. PubMed ID: 19015223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development.
    Zieger K; Marcussen N; Borre M; Ørntoft TF; Dyrskjøt L
    Int J Cancer; 2009 Nov; 125(9):2095-103. PubMed ID: 19637316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genomic imbalances in Schistosoma-associated and non-Schistosoma-associated bladder carcinoma. An array comparative genomic hybridization analysis.
    Armengol G; Eissa S; Lozano JJ; Shoman S; Sumoy L; Caballín MR; Knuutila S
    Cancer Genet Cytogenet; 2007 Aug; 177(1):16-9. PubMed ID: 17693186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of allele dosage at polymorphic microsatellite loci displaying allelic imbalance in tumors by means of quantitative competitive-polymerase chain reaction.
    Sjöling A; Walentinsson A; Nordlander C; Karlsson A; Behboudi A; Samuelson E; Levan G; Röhme D
    Cancer Genet Cytogenet; 2005 Mar; 157(2):97-103. PubMed ID: 15721629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.
    Szarvas T; Kovalszky I; Bedi K; Szendroi A; Majoros A; Riesz P; Füle T; László V; Kiss A; Romics I
    Oncol Rep; 2007 Aug; 18(2):405-9. PubMed ID: 17611663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of allelic imbalance in ascitic supernatant by digital single nucleotide polymorphism analysis.
    Chang HW; Ali SZ; Cho SK; Kurman RJ; Shih IeM
    Clin Cancer Res; 2002 Aug; 8(8):2580-5. PubMed ID: 12171887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms.
    Gunnarsson R; Staaf J; Jansson M; Ottesen AM; Göransson H; Liljedahl U; Ralfkiaer U; Mansouri M; Buhl AM; Smedby KE; Hjalgrim H; Syvänen AC; Borg A; Isaksson A; Jurlander J; Juliusson G; Rosenquist R
    Genes Chromosomes Cancer; 2008 Aug; 47(8):697-711. PubMed ID: 18484635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allelic dosage analysis with genotyping microarrays.
    Ishikawa S; Komura D; Tsuji S; Nishimura K; Yamamoto S; Panda B; Huang J; Fukayama M; Jones KW; Aburatani H
    Biochem Biophys Res Commun; 2005 Aug; 333(4):1309-14. PubMed ID: 15982637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allelic deletions of Rb and L-myc in urine sediments from patients with bladder tumors or carcinoma in situ.
    Primdahl H; von der Maase H; Christensen M; Wolf H; Ørntoft TF
    Oncol Rep; 2002; 9(3):551-5. PubMed ID: 11956626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder.
    Holyoake A; O'Sullivan P; Pollock R; Best T; Watanabe J; Kajita Y; Matsui Y; Ito M; Nishiyama H; Kerr N; da Silva Tatley F; Cambridge L; Toro T; Ogawa O; Guilford P
    Clin Cancer Res; 2008 Feb; 14(3):742-9. PubMed ID: 18245534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer.
    Zieger K; Wiuf C; Jensen KM; Ørntoft TF; Dyrskjøt L
    BMC Cancer; 2009 May; 9():149. PubMed ID: 19445696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
    Sørensen KD; Wild PJ; Mortezavi A; Adolf K; Tørring N; Heebøll S; Ulhøi BP; Ottosen P; Sulser T; Hermanns T; Moch H; Borre M; Ørntoft TF; Dyrskjøt L
    Clin Cancer Res; 2009 Feb; 15(4):1400-10. PubMed ID: 19228741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-resolution analysis of chromosomal imbalances using the Affymetrix 10K SNP genotyping chip.
    Herr A; Grützmann R; Matthaei A; Artelt J; Schröck E; Rump A; Pilarsky C
    Genomics; 2005 Mar; 85(3):392-400. PubMed ID: 15718106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clonal and parallel evolution of primary lung cancers and their metastases revealed by molecular dissection of cancer cells.
    Takahashi K; Kohno T; Matsumoto S; Nakanishi Y; Arai Y; Yamamoto S; Fujiwara T; Tanaka N; Yokota J
    Clin Cancer Res; 2007 Jan; 13(1):111-20. PubMed ID: 17200345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utility of incorporating genetic variants for the early detection of prostate cancer.
    Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
    Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Artificial intelligence and bladder cancer arrays.
    Wild PJ; Catto JW; Abbod MF; Linkens DA; Herr A; Pilarsky C; Wissmann C; Stoehr R; Denzinger S; Knuechel R; Hamdy FC; Hartmann A
    Verh Dtsch Ges Pathol; 2007; 91():308-19. PubMed ID: 18314629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ploidy status and copy number aberrations in primary glioblastomas defined by integrated analysis of allelic ratios, signal ratios and loss of heterozygosity using 500K SNP Mapping Arrays.
    Gardina PJ; Lo KC; Lee W; Cowell JK; Turpaz Y
    BMC Genomics; 2008 Oct; 9():489. PubMed ID: 18928532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications.
    Gorringe KL; Jacobs S; Thompson ER; Sridhar A; Qiu W; Choong DY; Campbell IG
    Clin Cancer Res; 2007 Aug; 13(16):4731-9. PubMed ID: 17699850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.